Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Honsea Sunshine Biotech is a specialized biotechnology company based in Guangzhou, China, focused on the research, development, and large-scale production of natural plant extracts. The company utilizes advanced supercritical CO2 extraction and molecular distillation technologies to produce high-purity active ingredients for the pharmaceutical, cosmetic, and nutraceutical industries. Their core product portfolio includes standardized extracts of ginger, magnolia bark, and rosemary, featuring high concentrations of bioactives such as gingerols, honokiol, and magnolol. Honsea Sunshine Biotech operates under strict quality management systems to provide natural solutions for anti-inflammatory, antimicrobial, and antioxidant applications. The company serves a global market, positioning itself as a key supplier for health and personal care formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Honsea Sunshine BioTech.